There has recently been a great increase in interest and availability of ionisers for use in both home and work environments. The manufacturers claim many benefits which range from the removal of tobacco smoke particles to preventing migraine and relieving asthma. While the removal of smoke particles is readily demonstrable, the relief of asthma is questionable. There have been several uncontrolled studies to investigate the effect on asthma, some showing temporary improvement in symptoms on exposure to negatively charged ionslA and others showing no effect.5 Only two studies have investigated the ionisation of air under controlled conditions.7
Methods-The effect of ionisers on airborne concentrations of house dust mite allergen Der p I was investigated in a double blind, crossover, placebo controlled trial in the homes of 20 children with allergic asthma. Subjects recorded their peak expiratory flow rate (PEFR) twice daily and completed a daily symptom score and treatment schedule on a diary card for two six week periods, one with an active ioniser and the other with a placebo ioniser (randomly allocated) used in the living room and the bedroom. Results-Airborne Der p I concentrations fell significandy during the active period compared with the placebo period, but there was no significant change in PEFR, symptom scores, or treatment usage. There was an increase in night time cough which almost reached significance during the active period. Conclusions-This study indicates that the use of ionisers cannot be recommended in the homes of asthmatic subjects to improve their symptoms. The significant reduction of airborne allergen concentrations may be of use as part of a multidevice allergen avoidance regimen, but the increase in night time cough requires fiurther study. (Thorax 1993; 48:330-333) There has recently been a great increase in interest and availability of ionisers for use in both home and work environments. The manufacturers claim many benefits which range from the removal of tobacco smoke particles to preventing migraine and relieving asthma. While the removal of smoke particles is readily demonstrable, the relief of asthma is questionable. There have been several uncontrolled studies to investigate the effect on asthma, some showing temporary improvement in symptoms on exposure to negatively charged ionslA and others showing no effect.5 Only two studies have investigated the ionisation of air under controlled conditions.7
Ben-Dov et a16 showed a significant attenuation in exercise induced asthma in patients breathing negatively ionised compared with non-ionised air, but there was no effect on the response to histamine. Nogrady and
Furness could find no effect of ionisers on PEFR, symptom score, or consumption of medications during a blind crossover study of active and placebo ionisers in adults with asthma.7 No studies have established whether ionisers reduce aeroallergen load coincident with clinical monitoring. This study investigated the efficiency of ionisers in reducing airborne house dust mite allergen (Der p I) in the homes of children with house dust mite induced asthma and the effect of reduced concentrations of the allergen on their symptoms.
PATIENTS
Twenty children with perennial asthma of median age 9 (range 3-11) years were selected from the Brompton Hospital asthma clinic. All children had a skin test reactivity of greater than or equal to 3 mm weal diameter when tested with standard house dust mite skin test solution (Dome Hollister Stier, 1200 PNU/ml) and were regular attenders at the asthma clinic for management of their asthma.
ANALYSIS OF HOMES
The airborne allergen content of patients' homes was assessed before enrolment into the study and only those with Der p I concentration in both the living room and the child's bedroom of greater than 2 ng/m3 air were enrolled.
Air sampling was performed as described previously.8 The Casella personal sampler (Casella, Bedford, UK) sampling 2 I/min was used for measurement of airborne Der p I. Three hour samples were collected in duplicate for each patient from the child's bedroom and from the living room in which the child spent most time. Normal domestic activities such as walking around the room and sitting on the furniture were in progress in the houses during the sampling periods, but dusting, vacuuming, and bedmaking were avoided.
FILTER EXTRACTION
The Casella personal sampler collects particulate matter onto a glass fibre filter that retains particles larger than 5 gm in diameter (Whatman, UK). For allergen determination the complete personal filter (25 mm) was extracted overnight with 1 ml PBS/Tween 05% (BDH, Poole, UK) with 0-2% bovine serum albumin (BDH) followed by sonication and filtration through a 0-2 gum filter (Whatman). Eluted samples were stored at -20°C until required for assay.
MEASUREMENT OF ALLERGENIC ACTIVITY BY ELISA
The level of Der p I was measured using the ALK (Denmark) ELISA system incorporating affinity purified monospecific antibody to Der p I according to the manufacturer's instructions. The assay was able to detect levels of Der p I above 1 ng/ml with an upper limit of 85% of the maximal response (340 ng/ml). The intra-assay variation was approximately 5-4% and the interassay variation about 14%.
IONISERS
The ionisers used in the study were Clear Air ionisers provided by Mr J Cleary of the London Ioniser Centre.
STUDY DESIGN
The trial was of a double blind crossover design. After the initial home visit to determine airborne allergen concentrations, the selected homes were randomly allocated to two groups of 10: (a) active period (six weeks) first, and (b) placebo period (six weeks) first. Air sampling was performed at the beginning, middle, and end of each ioniser period, and the ionisers were changed after the final sampling of the first period. Subjects were assessed by diary cards on which they recorded symptom scores, medication, and PEFR as measured with a Wright peak flow meter (in those children who could perform reproducible blows). PEFR was recorded before breakfast and bedtime medicines, the best of three blows on each occasion being measured. Symptoms were scored as follows: wheeze last night (0-3), cough last night (0-3), wheeze today (0-3), activity today (0-3), sputum production (0-2). Consumption of inhaled or oral bronchodilators, corticosteroids, sodium cromoglycate, and other medications was also recorded. All subjects were asked to record the data throughout the whole 12 week period. For each ioniser period they were asked to use the device in the living room during the day and the child's bedroom at night. It was not possible for the families or the investigators to determine whether the ioniser was active or placebo as both appeared identical, the only difference being that the placebo devices had no internal wiring and had been coded by the manufacturer. Mean morning and evening PEFRs were calculated for each period for each subject able to perform the tests (n = 14). Symptoms and bronchodilator use were scored as outlined above and mean scores for each period were calculated.
The study was approved by the Joint Ethical Committee of the Brompton Hospital and the National Heart and Lung Institute.
STATISTICAL ANALYSIS
Statistical analysis was performed to compare active and placebo periods using the Wilcoxon signed rank sum test for the clinical observations, and the X2 and Mann-Whitney U tests for the allergen measurements.
Results

Der p I CONCENTRATIONS
The changes in airborne Der p I concentrations during the active and placebo ioniser periods in the living rooms and bedrooms of the 20 houses are shown in the figure. There was a significant (p < 0-0001, Mann-Whitney U test) decrease in airborne Der p I concentrations in both bedrooms and living rooms during the active period compared with the placebo period. Table 1 Discussion Families with an asthmatic child are extremely susceptible to advertising in the media which suggests they can purchase a device that will reduce the likelihood that an asthma attack will be triggered. An ioniser which is claimed to remove dust from the air would most dramatic, however, there was no measurable improvement in asthma symptoms and it must also be noted that in a few houses there was actually an increase in Der p I in the air while the active ioniser was present.
There are many explanations for the lack of improvement in asthma symptoms. Because of the chronic inflammatory processes involved in asthma, six weeks may not be long enough to show changes in symptoms as a result of environmental manipulation. The home is not the only environment to which the children are exposed. Studies from Norway'" 12 have shown that children are also exposed to measurable levels of domestic allergens (house dust mite, cat, and dog) at school which may have a considerable effect on their symptoms. Allergens are released in large quantities from beds, carpets, and soft furnishings when they are disturbed and it has not yet been satisfactorily determined whether asthma symptoms are attributable to a long term average exposure to airborne allergens or to an intermittent exposure to high levels in dust clouds. Our results show that an ioniser is capable of reducing the background airborne allergen levels when little disturbance is occurring, but it may have no effect on intermittent exposure to high levels. This short duration, high level exposure may be enough to allow symptoms to persist. It is possible that ioniser equipment with a higher ion output than that used in this study might be more effective at controlling dust clouds, but this could only be established by conducting a similar controlled trial.
In those homes where airborne allergen levels increased during the active period it must be assumed that the ionisers interacted with the charge already existing within the room to allow more particles to remain airborne. This did not increase the children's symptoms, lending further support to the importance of short duration exposure levels.
The increase in night time cough while using the active ionisers came very close to significance. It has been suggested that this could be caused by the irritant effect on the airways of ozone produced by ionisers. This particular ioniser model, however, could not be shown to be producing measurable ozone when tested with Kitigawa Precision Gas Detector equipment in the rooms under study. It has also been suggested that charged ions can be irritant to airways in their own right and there is a considerable rise in ion counts in a room during the operation of an active ioniser.7 This is more likely to be a problem at night in an undisturbed bedroom where the ions are not dissipated and, indeed, where the door may be closed.
These results would not allow recommendation of ionisers of the type used in this study for relief of asthma symptoms despite their significant effect on airborne house dust mite concentrations. It may be worth noting, however, that three parents reported relief of rhinitis symptoms during the study and when investigated this relief was during the active period in each case. It is possible that such an approach could be used as an integral part of a much more complex allergen avoidance regimen where other techniques are used simultaneously to reduce the allergen concentrations in dust reservoirs such as beds and soft furnishings that produce the allergen clouds uncontrolled by an ioniser alone. Nevertheless, the effect on cough needs further investigation before such a recommendation could be made.
